The immune modulation by endocrine therapy can be intrinsic to cancer cells—via antagonizing the ER-mediated suppression of PD-L1 immune checkpoint [276]—or extrinsic to cancer cells via direct modulation of various immune cells [137]. Here, CD274 is linked to cancer.